SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitromycin and protease inhibitors is being empirically used, with reported data of QTc interval prolongation. Our aim is to assess QT interval behaviour in a not critically ill and not monitored cohort of patients. We evaluated admitted and ambulatory patients with COVID-19 patients with 12 lead electrocardiogram at 48 h after treatment initiation. Other clinical and analytical variables were collected. Statistical analysis was performed to assess the magnitude of the QT interval prolongation under treatment and to identify clinical, analytical and electrocardiographic risk markers of QT prolongation independent predictors. We i...
Chloroquine phosphate and hydroxychloroquine sulfate are used for treatment and prevention of compli...
Background: There is no known effective therapy for patients with COVID-19. Initial reports suggesti...
While facing potentially high morbidity from COVID-19 without known effective therapies, the off-lab...
SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxi...
SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxi...
Introduction: No data are provided about the effect of triple combination therapy with Lopinavir/Rit...
Background - The novel SARs-CoV-2 coronavirus is responsible for the global COVID-19 pandemic. Small...
Background: Prolonged QTc intervals and life-Threatening arrhythmias (LTA) are potential drug-induce...
Background: The prognostic value of a prolonged QT interval in SARS-Cov2 infection is not well known...
Since the first case recorded in the end of 2019, the virus SARS-CоV-2 and the related lung disease ...
Abstract Background Hydroxychloroquine/chloroquine (HCQ/CQ) treatment for COVID‐19 was associated wi...
Dataset from the article Bernardini A, Ciconte G, Negro G, Rondine R, Mecarocci V, Viva T, Santini F...
Indonesia has declared a COVID-19 outbreaks because of severe acute respiratory syndrome coronavirus...
Background: Hydroxychloroquine and azithromycin combination therapy is often prescribed for coronavi...
Background: In the battle against the SARS-CoV‑2 pandemic, chloroquine has emerged as a new potentia...
Chloroquine phosphate and hydroxychloroquine sulfate are used for treatment and prevention of compli...
Background: There is no known effective therapy for patients with COVID-19. Initial reports suggesti...
While facing potentially high morbidity from COVID-19 without known effective therapies, the off-lab...
SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxi...
SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxi...
Introduction: No data are provided about the effect of triple combination therapy with Lopinavir/Rit...
Background - The novel SARs-CoV-2 coronavirus is responsible for the global COVID-19 pandemic. Small...
Background: Prolonged QTc intervals and life-Threatening arrhythmias (LTA) are potential drug-induce...
Background: The prognostic value of a prolonged QT interval in SARS-Cov2 infection is not well known...
Since the first case recorded in the end of 2019, the virus SARS-CоV-2 and the related lung disease ...
Abstract Background Hydroxychloroquine/chloroquine (HCQ/CQ) treatment for COVID‐19 was associated wi...
Dataset from the article Bernardini A, Ciconte G, Negro G, Rondine R, Mecarocci V, Viva T, Santini F...
Indonesia has declared a COVID-19 outbreaks because of severe acute respiratory syndrome coronavirus...
Background: Hydroxychloroquine and azithromycin combination therapy is often prescribed for coronavi...
Background: In the battle against the SARS-CoV‑2 pandemic, chloroquine has emerged as a new potentia...
Chloroquine phosphate and hydroxychloroquine sulfate are used for treatment and prevention of compli...
Background: There is no known effective therapy for patients with COVID-19. Initial reports suggesti...
While facing potentially high morbidity from COVID-19 without known effective therapies, the off-lab...